AssuredPartners Investment Advisors LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 80.6% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,256 shares of the healthcare conglomerate’s stock after selling 5,214 shares during the period. AssuredPartners Investment Advisors LLC’s holdings in UnitedHealth Group were worth $392,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC grew its holdings in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares during the period. Revolve Wealth Partners LLC boosted its position in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of UnitedHealth Group by 7.4% during the 1st quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate’s stock worth $8,295,000 after purchasing an additional 1,089 shares in the last quarter. Curran Financial Partners LLC lifted its position in UnitedHealth Group by 4.0% in the 1st quarter. Curran Financial Partners LLC now owns 756 shares of the healthcare conglomerate’s stock valued at $396,000 after acquiring an additional 29 shares in the last quarter. Finally, Blue Trust Inc. lifted its position in UnitedHealth Group by 9.8% in the 1st quarter. Blue Trust Inc. now owns 9,213 shares of the healthcare conglomerate’s stock valued at $4,825,000 after acquiring an additional 823 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Stock Performance
UnitedHealth Group stock opened at $356.53 on Friday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $322.90 billion, a PE ratio of 15.45, a P/E/G ratio of 2.31 and a beta of 0.47. The firm has a fifty day simple moving average of $329.38 and a two-hundred day simple moving average of $344.86. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.
Wall Street Analysts Forecast Growth
UNH has been the topic of several recent analyst reports. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Wednesday, October 8th. Wells Fargo & Company raised their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Cantor Fitzgerald reissued an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, Truist Financial raised their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Eighteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Hold” and an average price target of $385.13.
Read Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- How Investors Can Find the Best Cheap Dividend Stocks
- This AI Chip Giant Could Be the Market’s Next Big Winner
- How to start investing in penny stocks
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.